Piramal Healthcare to present phase I data for oral anticancer molecule at ASCO
Piramal Healthcare announced that phase I clinical trial data for its investigational new drug candidate P1446A-05 will be…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.